Skip to main content
Premium Trial:

Request an Annual Quote

Ontario Cancer Institute Taps Geospiza for Genetic Analysis Software

NEW YORK (GenomeWeb News) – The Ontario Institute for Cancer Research will use Geospiza’s genetic analysis software in its sequencing programs for cancer research, the company said today.
 
Under the agreement, Toronto-based OICR will use the company’s FinchLab software in its cancer studies. The not-for-profit institute is funded by the Ontario government under the Ministry of Research and Innovation.
 
In April, OICR said it received CA$60 million ($58.8 million), which it plans to spend on building up its cancer research program, starting new initiatives, and stocking up on new equipment.
 
The FinchLab platform will support analysis projects for data from OICR’s next-generation sequencing instruments, such as the Illumina Genome Analyzer and Applied Biosystems’ SOLiD, the Seattle-based company said.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.